vcfirmsdirectory.com

Venture capital · Early stage · Est. 2007

The Column Group

The Column Group is a San Francisco-based life sciences venture firm that forms and funds biotech companies, supporting them from inception through exit with a family of related funds.

San FranciscoRegistered · San Francisco
New investments · 12 months
Fund vehiclesPublic
15
15 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: thecolumngroup.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round The Column Group joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is The Column Group right for your round?

Is The Column Group a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
15
15 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

THE COLUMN GROUP IV, LPUS private fund · Active · United States · $730.1M gross assets · filed 19 Mar 2026
THE COLUMN GROUP V LPUS private fund · Active · United States · $533.5M gross assets · filed 19 Mar 2026
THE COLUMN GROUP OPPORTUNITY III LPUS private fund · Active · United States · $489.2M gross assets · filed 19 Mar 2026
THE COLUMN GROUP OPPORTUNITY IV, LPUS private fund · Active · United States · $270.6M gross assets · filed 19 Mar 2026
THE COLUMN GROUP VI, LPUS private fund · Active · United States · $270.6M gross assets · filed 19 Mar 2026
THE COLUMN GROUP II, LPUS private fund · Active · United States · $205.7M gross assets · filed 19 Mar 2026
THE COLUMN GROUP IIIA, LPUS private fund · Active · United States · $139.7M gross assets · filed 19 Mar 2026
THE COLUMN GROUP III, LPUS private fund · Active · United States · $123.6M gross assets · filed 19 Mar 2026
PONOI CAPITAL LPUS private fund · Active · United States · $100.8M gross assets · filed 19 Mar 2026
THE COLUMN GROUP - NEURO II, LPUS private fund · Active · United States · $98.5M gross assets · filed 19 Mar 2026
THE COLUMN GROUP - NEURO, LPUS private fund · Active · United States · $93.1M gross assets · filed 19 Mar 2026
THE COLUMN GROUP, LPUS private fund · Active · United States · $88.8M gross assets · filed 19 Mar 2026
3 more fund vehiclesSEC adviser filings
Deployed (new cheques)
Next fund expected

Latest investments

BetaRounds The Column Group joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

6 rounds in the last 12 months

Round sizes, The Column Group’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

Sentrin TherapeuticsTopo TherapeuticsNilo TherapeuticsSurrozenMonimoi TherapeuticsSyntheXTortugas NeuroscienceJudo BioCarmot TherapeuticsPeloton Therapeuticsand 33 more

Portfolio and exits

Every company The Column Group backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where The Column Group puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet The Column Group

Events where The Column Group’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet The Column Group’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

1 Oct 2026New deal
16 Sep 2026New deal
12 Aug 2026New deal
22 Jun 2026New deal
19 Mar 2026Fund filingForm ADV filed by THE COLUMN GROUP: 15 private funds, $3.3B in gross assets.SEC Form ADV · public record
5 Mar 2026New deal
18 Dec 2025New deal
3 Apr 2025New deal

Founders also look at

Frequently asked questions

The Column Group is based in San Francisco, United States.

In 2007.

15 fund vehicles are on public registers (SEC adviser filings), including THE COLUMN GROUP IV, LP, THE COLUMN GROUP V LP and THE COLUMN GROUP OPPORTUNITY III LP.

Stages: Early stage. Sectors: Life sciences. From the firm’s own website.

TCG focuses on company formation in biotech, backing science-driven teams from early platform and drug discovery through later-stage programs and exit. It runs an ecosystem of funds with distinct strategies and offers hands-on help with leadership and talent recruitment. From the firm’s own website.

The Column Group lists 43 portfolio companies on its website, including Sentrin Therapeutics, Topo Therapeutics, Nilo Therapeutics, Surrozen and Monimoi Therapeutics.

Firms whose websites list some of the same companies include RA Capital, Atlas Venture and Foresite Capital.

Know before The Column Group’s next round is announced.

PRO tracks The Column Group’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

The Column GroupGet The Column Group’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.